Diabetic HDL is dysfunctional in stimulating endothelial cell migration and proliferation due to down regulation of

Bing Pan1, Yijing Ma, Hui Ren

  • 1The Institute of Cardiovascular Sciences, Ministry of Education, Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Ministry of Health, Peking University Health Science Center, Beijing, China.

Plos One
|November 8, 2012
PubMed

Insights

Diabetic high-density lipoprotein (HDL) dysfunction impairs endothelial cell function due to reduced SR-BI receptor levels. This downregulation affects cell proliferation, migration, and chronic Akt activation.

Area of Science:

  • Cardiovascular Biology
  • Endocrinology
  • Lipid Metabolism

Background:

  • Diabetic high-density lipoprotein (HDL) exhibits reduced capacity to stimulate endothelial cell (EC) proliferation, migration, and adhesion.
  • The underlying mechanisms of diabetic HDL dysfunction remain incompletely understood.

Purpose of the Study:

  • To investigate the mechanistic features contributing to diabetic HDL dysfunction.
  • To elucidate the role of the HDL receptor scavenger receptor class B type 1 (SR-BI) in diabetic HDL's effects on ECs.

Main Methods:

  • Assessed the impact of normal and diabetic HDL on human umbilical vein endothelial cells (HUVECs) and mouse aortic endothelial cells (MAECs).
  • Investigated the expression and function of SR-BI in ECs treated with different HDL types.
  • Analyzed Akt phosphorylation in response to HDL treatment over time.

Main Results:

  • Diabetic HDL-induced endothelial dysfunction was associated with decreased SR-BI protein levels.
  • SR-BI downregulation significantly impaired the proliferative and migratory effects of normal HDL on MAECs.
  • While both normal and diabetic HDL induced acute Akt phosphorylation, diabetic HDL showed reduced chronic Akt activation, linked to SR-BI downregulation.

Conclusions:

  • Diabetic HDL dysfunction in promoting EC proliferation, migration, and adhesion is linked to SR-BI downregulation.
  • Reduced SR-BI expression diminishes diabetic HDL's capacity for chronic Akt activation, contributing to endothelial dysfunction.
Abstract

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...